Covista Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 6, 2026
CVSA$113.98+3.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
| (a) | None. |
| (b) | On June 8, 2026, Mr. Michael Betz, Covista’s Chief Growth and Innovation Officer and President of Walden University, entered in a Rule 10b5-1 Trading Arrangement (a “10b5-1 Plan”). Mr. Betz’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Sales pursuant to the 10b5-1 Plan will begin no earlier than September 8, 2026. The 10b5-1 Plan end date is December 1, 2026. The 10b5-1 Plan governs Mr. Betz’s sale of 12,600 shares of Covista common stock. After such sales, Mr. Betz will continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.